Xtl Biopharmaceuticals (XTLB) Liabilities and Shareholders Equity (2009 - 2025)
Xtl Biopharmaceuticals' Liabilities and Shareholders Equity came in at $166,000 for the quarter ended Dec 31, 2025, down 98.1% from $8.55 million a year earlier.
Powered by 
Analysis
Xtl Biopharmaceuticals (XTLB) Liabilities and Shareholders Equity (2009 - 2025) Analysis & Trends
Going back to the quarter ended Mar 31, 2009, Xtl Biopharmaceuticals' Liabilities and Shareholders Equity data covers 66 quarters.
- Liabilities and Shareholders Equity carries a five-year compound annual growth rate of -52.0% (years ended Dec 2020 to Dec 2025).
- Going back by year, Liabilities and Shareholders Equity was $8.55 million in the year ended Dec 31, 2024 (+252.4%), $2.43 million in the year ended Dec 31, 2023 (-42.0%), $4.19 million in the year ended Dec 31, 2022 (-36.7%) and $6.62 million in the year ended Dec 31, 2021 (+1.8%).
- The figure for the quarter ended Dec 31, 2025 represents the lowest quarterly Liabilities and Shareholders Equity in data going back to the quarter ended Mar 31, 2009.
- Year-over-year, Liabilities and Shareholders Equity increased in two of the last six quarters, with growth averaging 50.7%.
- The fastest year-over-year change in Liabilities and Shareholders Equity over five years came in the quarter ended Dec 31, 2024 (growth of 252.4%), and the weakest in the quarter ended Dec 31, 2025 (a decline of 98.1%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Xtl Biopharmaceuticals | 2.27 Bn | 2.27 Bn | - | 166,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 166,000.00 |
| Jun 30, 2025 | 714,000.00 |
| Dec 31, 2024 | 8.55 Mn |
| Sep 30, 2024 | 9.28 Mn |
| Jun 30, 2024 | 2.40 Mn |
| Mar 31, 2024 | 2.93 Mn |
| Dec 31, 2023 | 2.43 Mn |
| Sep 30, 2023 | 2.66 Mn |
| Jun 30, 2023 | 2.88 Mn |
| Mar 31, 2023 | 3.32 Mn |
| Dec 31, 2022 | 4.19 Mn |
| Sep 30, 2022 | 4.90 Mn |
| Jun 30, 2022 | 5.76 Mn |
| Mar 31, 2022 | 6.62 Mn |
| Dec 31, 2021 | 6.62 Mn |
| Sep 30, 2021 | 6.86 Mn |
| Jun 30, 2021 | 6.95 Mn |
| Mar 31, 2021 | 7.31 Mn |
| Dec 31, 2020 | 6.50 Mn |
| Sep 30, 2020 | 6.21 Mn |
API Access
Xtl Biopharmaceuticals Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=XTLB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "XTLB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=XTLB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();